I. Tannock
Oncology · Nature Reviews. Cancer · 2000–2014
A researcher in the Science corpus: 11 papers; trusts 5 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 74 citations into it; #481 of 1,698 by trust here, #435 by citations
- Molecular Biology — 51 citations into it
- Cancer Research — 37 citations into it
- Immunology — 34 citations into it
- Immunology and Allergy — 7 citations into it
- Radiology, Nuclear Medicine and Imaging — 6 citations into it
Whom I. Tannock trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts I. Tannock overall
Papers from I. Tannock's perspective
Ordered by how strongly the researchers I. Tannock trusts endorse each paper. Same corpus, a different order for every researcher.
- Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
- Hypoxia — a key regulatory factor in tumour growth (Nature Reviews. Cancer)
- Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (Cancer Research)
- Tumour biology: Herceptin acts as an anti-angiogenic cocktail (Nature)
- Hallmarks of cancer: the next generation. (Cell)
- Repopulation of cancer cells during therapy: an important cause of treatment failure (Nature Reviews. Cancer)
- Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. (Trends in immunology)
- Molecular regulation of vessel maturation (Nature Medicine)
- Why do cancers have high aerobic glycolysis? (Nature Reviews. Cancer)
- From inflammation to sickness and depression: when the immune system subjugates the brain (Nature Reviews Neuroscience)
Their papers
- A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer (2000) — 1,158 citations
- Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. (2014) — 3,049 citations
- Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. (2014) — 1,462 citations
- Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis (2014) — 681 citations
- Cytokines and their relationship to the symptoms and outcome of cancer (2008) — 605 citations
- Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. (2008) — 2,212 citations
- Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. (2008) — 1,169 citations
- Drug resistance and the solid tumor microenvironment. (2007) — 2,057 citations
- Drug penetration in solid tumours (2006) — 2,678 citations
- Repopulation of cancer cells during therapy: an important cause of treatment failure (2005) — 690 citations
- Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. (2004) — 5,761 citations